Trademark: 97607736
Word
EMED COVID/FLU TELEHEALTH
Status
Dead
Status Code
602
Status Date
Monday, May 20, 2024
Serial Number
97607736
Mark Type
4
Filing Date
Monday, September 26, 2022
Abandoned Date
Wednesday, May 1, 2024

Trademark Owner History

Classifications
41 Education services, namely, providing digital education content in the nature of online non-downloadable blogs and articles relating to disease; Education services, namely, providing one-on-one instruction in the field of self-administered health screening, self-administered health assessments, using at-home diagnostic tests, taking at-home diagnostic tests, self-administered diagnostic testing, and at-home diagnostic testing; Providing training in the field of self-administered health screening, self-administered health assessments, using at-home diagnostic tests, taking at-home diagnostic tests, self-administered diagnostic testing, and at-home diagnostic testing; all the foregoing for the detection, screening, and monitoring of COVID-19 and influenza
9 Downloadable software and downloadable mobile applications for use in connection with detecting, screening, and monitoring the presence of diseases; downloadable software and downloadable mobile applications for use in connection with providing medical and health related education and training; downloadable software and downloadable mobile applications for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; all the foregoing for the detection, screening, and monitoring of COVID-19 and influenza
39 Delivery of medicine, prescription drugs, and therapeutic products
38 Audio teleconferencing; Instant messaging services; Network conferencing services; Teleconferencing services; Video conferencing services; Video teleconferencing
5 Diagnostic preparations for medical purposes; medical diagnostic rapid test kits comprised primarily of chemical medical diagnostic reagents and solvents in the nature of assays and also including swabs, vials, and containers for medical use for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; medical diagnostic media for cultures for use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; rapid diagnostic test kits for medical purposes comprised primarily of chemical reagents and solvents in the nature of assays an also including swabs, vials and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; all the foregoing for the detection, screening, and monitoring of COVID-19 and influenza
1 Rapid diagnostic test kits for scientific and research use comprised primarily of chemical reagents and solvents other than for medical or veterinary purposes and also including swabs, vials, and containers for medical use for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; media for cell cultures for scientific and research use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; all the foregoing for the detection, screening, and monitoring of COVID-19 and influenza
45 Prescription drug release verification services as part of personal background analysis of courier service providers; all the foregoing for the detection, screening and monitoring of COVID-19 and influenza
44 Telemedicine services, namely, providing remote proctoring of diagnostic tests; providing digital educational health information relating to disease; all the foregoing for the detection, screening and monitoring of COVID-19 and influenza
42 Providing on-line, non-downloadable internet-based software for use in detecting, screening and monitoring the presence of diseases; providing on-line, non-downloadable cloud-based software for use in detecting, screening and monitoring the presence of diseases; software as a service (SAAS) services featuring software for use in detecting, screening and monitoring the presence of diseases; platform as a service (PAAS) featuring computer software platforms for detecting, screening, and monitoring the presence of diseases; providing on-line, non-downloadable internet-based software for use in conducting medical and health related education and training; providing on-line, non-downloadable cloud-based software for use in conducting medical and health related education and training; software as a service (SAAS) services featuring software for use in conducting medical and health related education and training; platform as a service (PAAS) featuring computer software platforms for use in conducting medical and health related education and training; providing on-line, non-downloadable internet-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing on-line, non-downloadable cloud-based software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; platform as a service (PAAS) featuring computer software platforms for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; providing temporary use of on-line non-downloadable software applications for use in connection with detecting, screening, and monitoring the presence of diseases; providing temporary use of on-line non-downloadable mobile applications for use in conducting medical and health related education and training; providing temporary use of on-line non-downloadable software applications for use in connection with data and information management, receipt, storage, display, tracking, sharing, management, monitoring, and analysis; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for live digital communications, namely, live video and audio conferencing with multiple simultaneous users, teleconferencing, and network conferencing; software as a service (SAAS) services featuring software for providing a non-downloadable online platform to enable workflow management of a proctored examination; software as a service (SAAS) services featuring software for providing a non-downloadable online platform to enable video conferencing connectivity between proctors and users to conduct a proctored test; platform as a service (PAAS) featuring computer software platforms for proctoring of exams; platform as a service (PAAS) featuring computer software platforms for providing online identity verification services and for creating identity verification reports; platform as a service (PAAS) featuring computer software platforms for providing process verification services for businesses and for creating process verification reports; providing online non-downloadable cloud based software as a service (SAAS) services, comprising AI-enabled proctoring to ensure integrity of remote assessments with real-time image, audio, and video proctoring, assessing functional, programming, technical and communication skills in real-time with video interviews, preventing cheating using AI, and conducting video interviews; software as a service (SAAS) services featuring software for secure exam proctoring and content protection, identification verification, and data analytics associated therewith; software as a service (SAAS) services featuring software for providing proctored examination testing, examination monitoring, and for reporting examination results to government agencies, insurers, employers, companies, and users; providing temporary use of on-line non-downloadable cloud-based computer software for autonomous online proctoring and identity verification; providing temporary use of online non-downloadable software for enabling video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables users to order diagnostic tests, to take diagnostic tests online with the guidance of a proctor, to view and access test results, and to order pharmaceuticals and prescriptions; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables AI-based guidance through self-administered diagnostic tests; software as a service (SAAS) services featuring software for providing an online platform that enables users to access digital health results; identity verification services, namely, providing electronic verification of on-line test results and generating electronic permission codes which then allow users to access said digital content; providing user authentication of personal identifying information via secure storage and transmission of supporting evidence via the internet for online software applications; providing user authentication of personal identifying information via video conference for online software applications; providing document verification services, namely, providing remote identity document scanning being electronic scanning of personally identifying photographic images, photo scanning, digitization of documents, data extraction being data encryption, data decryption; providing prescription drug release user authentication services via secure storage and transmission of supporting evidence via the internet for online software applications; providing user authentication services for using software technology for personal identity verification for telemedicine; all the foregoing for the detection, screening, and monitoring of COVID-19 and influenza
EMED COVID/FLU TELE HEALTH
"COVID/FLU TELEHEALTH"

Trademark Events
Sep 29, 2022
New Application Entered
Oct 13, 2022
New Application Office Supplied Data Entered
Mar 6, 2023
Assigned To Examiner
Mar 27, 2023
Assigned To Examiner
Apr 10, 2023
Teas Change Of Owner Address Received
Apr 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 10, 2023
Teas Change Of Correspondence Received
Apr 10, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 18, 2023
Non-Final Action Written
Apr 18, 2023
Non-Final Action E-Mailed
Apr 18, 2023
Notification Of Non-Final Action E-Mailed
Jul 14, 2023
Teas Response To Office Action Received
Jul 14, 2023
Correspondence Received In Law Office
Jul 14, 2023
Teas/Email Correspondence Entered
Oct 30, 2023
Final Refusal Written
Oct 30, 2023
Final Refusal E-Mailed
Oct 30, 2023
Notification Of Final Refusal Emailed
Dec 19, 2023
Application Extension To Response Period - Received
Dec 19, 2023
Application Extension Granted/Receipt Provided
May 20, 2024
Abandonment - Failure To Respond Or Late Response
May 20, 2024
Abandonment Notice E-Mailed - Failure To Respond

Trademark Alertz updated from USPTO on 2030-01-24